Author: Reuters

By Ronnie Cohen (Reuters Health) – For the past four years, since Facebook and Apple began paying for employees to freeze their eggs to delay childbirth, healthy women are increasingly trying to slow their biological...

By Shereen Lehman (Reuters Health) – Canadians who cannot afford to eat regularly or to eat a healthy diet have more than double the average risk of developing type 2 diabetes, a study suggests. To reduce the burden of...

By Deena Beasley (Reuters) – U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3...

By Valerie Volcovici WASHINGTON (Reuters) – The U.S. Environmental Protection Agency, under pressure from the chemical industry, has delayed release of a study detailing cancer risks from formaldehyde, according to...

By Lisa Rapaport (Reuters Health) – Commuters who abandon their cars in favor of walking or biking to work are less likely to develop heart disease or to die from it than people who drive to the office, a recent study...

By Mary Gillis (Reuters Health) – Another benefit of a healthy diet may be protection against age-related hearing loss, suggests a large study of U.S. women. Researchers followed more than 80,000 women for 26 years and...

By Carolyn Crist (Reuters Health) – Sleep-tracking devices and mobile apps can help engage users in improving sleep health, but none of the consumer technologies has been proven accurate or validated to screen for sleep...

(Reuters) – Shares of Inogen Inc fell nearly 7 percent on Thursday after short seller Citron Research called the oxygen supply device maker the most expensive name in medical technology with no pipeline. Shares of the...

ZURICH (Reuters) – Novartis said its Sandoz division received approval from the European Commission for its biosimilar Zessly (infliximab) in gastroenterological, rheumatological and dermatological diseases. Zessly is...